Global Search

Search articles, concepts, and chapters

Section II · Clinical Forms

Chapter 14: Developmental Glaucomas with Associated Anomalies

Shields' Textbook of Glaucoma, 6th edition

Showing 1–20 of 404 articles

11.
Cross-Sectional Study

Optic disc morphology in congenital glaucoma.

Panigrahi Arnav, Sawant Nikhil, Malik Manzoor Ahmad et al.

Eye (Lond)May 2025

This study found optic disc morphology in primary congenital glaucoma children is similar to healthy controls, despite axial elongation, suggesting these features aren't primary glaucoma indicators.

20.
Basic Science

In Search of Mouse Models for Exfoliation Syndrome.

Kuchtey Rachel W, Insignares Samuel, Yang Tzushan S et al.

Am J OphthalmolJun 20243 citations

Researchers studied double mutant mice with combined elastic fiber and microfibril defects as a model for Exfoliation Syndrome. These mice showed severe systemic and ocular abnormalities, but not elevated eye pressure, suggesting early retinal dysfunction and a link to systemic diseases.

1 / 21

Epiretinal membrane (ERM) was significantly more prevalent in pseudoexfoliation glaucoma (PXG) eyes (28.8%) compared to pseudoexfoliation syndrome (PXS) eyes (19.6%) and controls (8.5%) (P<0.001).

EpidemiologyCohortRetrospective Cohort Studyn=258 eyes from 160 participants

After age adjustment, pseudoexfoliation glaucoma (PXG) was independently associated with epiretinal membrane (ERM), with approximately 3.6-fold higher odds compared with controls (OR=3.58; 95% CI: 1.34-9.57; P=0.011).

PrognosisCohortRetrospective Cohort Studyn=258 eyes from 160 participants

In pseudoexfoliation glaucoma (PXG) patients, eyes with epiretinal membrane (ERM) showed significantly reduced visual field index (VFI) (P=0.011) and mean deviation (MD) (P=0.034) compared to eyes without ERM.

PrognosisCohortRetrospective Cohort Studyn=258 eyes from 160 participants

Multivariate regression identified both epiretinal membrane (ERM) presence and reduced retinal nerve fiber layer thickness (RNFLT) as independent predictors of visual field loss in pseudoexfoliation glaucoma (PXG) patients.

PrognosisCohortRetrospective Cohort Studyn=258 eyes from 160 participants

Routine optical coherence tomography (OCT) assessment in pseudoexfoliation syndrome (PXS) and pseudoexfoliation glaucoma (PXG) patients may facilitate early detection of epiretinal membrane (ERM) and improve visual prognosis.

DiagnosisExpert OpinionRetrospective Cohort Studyn=258 eyes from 160 participants

The 4-year cumulative incidence rate of perimetric glaucoma in eyes with pseudoexfoliation syndrome (PXF) without ocular hypertension (OHTN) was 26.5% (95% CI: 20.7-32.0%).

PrognosisCohortRetrospective cohort studyn=485 eyes from 369 patients

The 4-year cumulative incidence rate of perimetric glaucoma in eyes with pseudoexfoliation syndrome (PXF) with ocular hypertension (OHTN) was 37.5% (95% CI: 24.3-48.4%), which was significantly higher than in eyes without OHTN (log-rank test, P = 0.005).

PrognosisCohortRetrospective cohort studyn=485 eyes from 369 patients

Factors associated with incident glaucoma in pseudoexfoliation syndrome (PXF) included older age (HR: 1.39 [95% CI: 1.19-1.62], per 5 years), ocular hypertension (OHTN) (2.18 [1.39-3.42]), higher cup-to-disc ratio (CDR, 1.17 [1.04-1.31], per 0.1 higher CDR), and phakia (1.94 [1.13-3.34]).

PrognosisCohortRetrospective cohort studyn=485 eyes from 369 patients

87.3% of eyes with pseudoexfoliation syndrome (PXF) that developed glaucoma had no documented ocular hypertension (OHTN), based on measured IOP at any office visit.

DiagnosisCohortRetrospective cohort studyn=485 eyes from 369 patients

Incident ocular hypertension (OHTN) was observed in 14.6% of eyes with pseudoexfoliation syndrome (PXF) without baseline OHTN during follow-up.

EpidemiologyCohortRetrospective cohort studyn=485 eyes from 369 patients

At 12 months, after switching from latanoprost to latanoprostene bunod (LBN) monotherapy (0.024%), the mean intraocular pressure (IOP) reduction in pseudoexfoliation glaucoma (PXFG) patients was -16.7% (p < 0.001 vs. baseline).

TreatmentCohortRetrospective Cohortn=30 patients with PXFG

In a 12-month real-world clinical study, pseudoexfoliation glaucoma (PXFG) eyes treated with latanoprostene bunod (LBN) monotherapy (0.024%) experienced significantly greater intraocular pressure (IOP) lowering than primary open-angle glaucoma (POAG) eyes (p = 0.033) and neovascular glaucoma (NVG) eyes (p < 0.001).

Comparative EffectivenessCohortRetrospective Cohortn=103 patients (POAG n=42, PXFG n=30, NVG n=31)